Ureteral metastasis from prostate cancer

Hiroshi Hongo, Takeo Kosaka, Shunsuke Yoshimine, Mototsugu Oya

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A 59-year-old man had an elevated prostate-specific antigen (PSA) concentration (439 ng/mL) in December 2008. We diagnosed prostatic adenocarcinoma by prostate needle biopsy. CT and MRI showed a prostatic tumour with bone and lymph node metastases. Combined androgen blockade therapy reduced the PSA level temporarily. After the PSA level gradually started to increase again and reached 27.27 ng/mL in October 2010, the patient was diagnosed with castration-resistant prostate cancer and treated with docetaxel chemotherapy. Radiological examination detected left hydronephrosis and a tumour in the left lower ureter in March 2011. Retrograde pyelography and urine cytology of class 3 from the left ureter indicated that the ureteral mass was a urothelial carcinoma. A left nephroureterectomy was performed. After the operation, the pathological examination showed a metastatic prostate carcinoma, accompanied by a decrease in the serum PSA level from 59.56 to 45.33 ng/mL.

Original languageEnglish
JournalBMJ Case Reports
Volume2014
DOIs
Publication statusPublished - 2014

Fingerprint

Prostate-Specific Antigen
Prostatic Neoplasms
Neoplasm Metastasis
docetaxel
Ureter
Prostate
Carcinoma
Hydronephrosis
Urography
Castration
Needle Biopsy
Androgens
Cell Biology
Neoplasms
Adenocarcinoma
Lymph Nodes
Urine
Bone and Bones
Drug Therapy
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ureteral metastasis from prostate cancer. / Hongo, Hiroshi; Kosaka, Takeo; Yoshimine, Shunsuke; Oya, Mototsugu.

In: BMJ Case Reports, Vol. 2014, 2014.

Research output: Contribution to journalArticle

Hongo, Hiroshi ; Kosaka, Takeo ; Yoshimine, Shunsuke ; Oya, Mototsugu. / Ureteral metastasis from prostate cancer. In: BMJ Case Reports. 2014 ; Vol. 2014.
@article{06027be703334b588d8ea77af9ce3711,
title = "Ureteral metastasis from prostate cancer",
abstract = "A 59-year-old man had an elevated prostate-specific antigen (PSA) concentration (439 ng/mL) in December 2008. We diagnosed prostatic adenocarcinoma by prostate needle biopsy. CT and MRI showed a prostatic tumour with bone and lymph node metastases. Combined androgen blockade therapy reduced the PSA level temporarily. After the PSA level gradually started to increase again and reached 27.27 ng/mL in October 2010, the patient was diagnosed with castration-resistant prostate cancer and treated with docetaxel chemotherapy. Radiological examination detected left hydronephrosis and a tumour in the left lower ureter in March 2011. Retrograde pyelography and urine cytology of class 3 from the left ureter indicated that the ureteral mass was a urothelial carcinoma. A left nephroureterectomy was performed. After the operation, the pathological examination showed a metastatic prostate carcinoma, accompanied by a decrease in the serum PSA level from 59.56 to 45.33 ng/mL.",
author = "Hiroshi Hongo and Takeo Kosaka and Shunsuke Yoshimine and Mototsugu Oya",
year = "2014",
doi = "10.1136/bcr-2014-206736",
language = "English",
volume = "2014",
journal = "BMJ Case Reports",
issn = "1757-790X",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Ureteral metastasis from prostate cancer

AU - Hongo, Hiroshi

AU - Kosaka, Takeo

AU - Yoshimine, Shunsuke

AU - Oya, Mototsugu

PY - 2014

Y1 - 2014

N2 - A 59-year-old man had an elevated prostate-specific antigen (PSA) concentration (439 ng/mL) in December 2008. We diagnosed prostatic adenocarcinoma by prostate needle biopsy. CT and MRI showed a prostatic tumour with bone and lymph node metastases. Combined androgen blockade therapy reduced the PSA level temporarily. After the PSA level gradually started to increase again and reached 27.27 ng/mL in October 2010, the patient was diagnosed with castration-resistant prostate cancer and treated with docetaxel chemotherapy. Radiological examination detected left hydronephrosis and a tumour in the left lower ureter in March 2011. Retrograde pyelography and urine cytology of class 3 from the left ureter indicated that the ureteral mass was a urothelial carcinoma. A left nephroureterectomy was performed. After the operation, the pathological examination showed a metastatic prostate carcinoma, accompanied by a decrease in the serum PSA level from 59.56 to 45.33 ng/mL.

AB - A 59-year-old man had an elevated prostate-specific antigen (PSA) concentration (439 ng/mL) in December 2008. We diagnosed prostatic adenocarcinoma by prostate needle biopsy. CT and MRI showed a prostatic tumour with bone and lymph node metastases. Combined androgen blockade therapy reduced the PSA level temporarily. After the PSA level gradually started to increase again and reached 27.27 ng/mL in October 2010, the patient was diagnosed with castration-resistant prostate cancer and treated with docetaxel chemotherapy. Radiological examination detected left hydronephrosis and a tumour in the left lower ureter in March 2011. Retrograde pyelography and urine cytology of class 3 from the left ureter indicated that the ureteral mass was a urothelial carcinoma. A left nephroureterectomy was performed. After the operation, the pathological examination showed a metastatic prostate carcinoma, accompanied by a decrease in the serum PSA level from 59.56 to 45.33 ng/mL.

UR - http://www.scopus.com/inward/record.url?scp=84930064345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930064345&partnerID=8YFLogxK

U2 - 10.1136/bcr-2014-206736

DO - 10.1136/bcr-2014-206736

M3 - Article

VL - 2014

JO - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

ER -